UA103558C2 - Таблетка пролонгованого вивільнення, що містить теобромін - Google Patents

Таблетка пролонгованого вивільнення, що містить теобромін

Info

Publication number
UA103558C2
UA103558C2 UAA201206606A UAA201206606A UA103558C2 UA 103558 C2 UA103558 C2 UA 103558C2 UA A201206606 A UAA201206606 A UA A201206606A UA A201206606 A UAA201206606 A UA A201206606A UA 103558 C2 UA103558 C2 UA 103558C2
Authority
UA
Ukraine
Prior art keywords
sustained release
theobromine
tablet containing
release layer
release tablet
Prior art date
Application number
UAA201206606A
Other languages
English (en)
Russian (ru)
Inventor
Джин АУХ
Чан-Хван КИМ
Чан-Кюн ХАН
Хён-Гун ДЖОН
Ян-Джоон КИМ
Джон-Гиал КИМ
Джу-Йон Йоун
Джун-Хва ЛЕЕ
Original Assignee
Ахн-Гоок Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ахн-Гоок Фармасьютикал Ко., Лтд. filed Critical Ахн-Гоок Фармасьютикал Ко., Лтд.
Publication of UA103558C2 publication Critical patent/UA103558C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується таблетки пролонгованого вивільнення, яка містить теобромін та складається з шару пролонгованого вивільнення і шару швидкого вивільнення. Таблетка за винаходом ефективно пригнічує різні типи симптомів кашлю при прийомі тільки один раз на добу.
UAA201206606A 2009-11-02 2010-09-01 Таблетка пролонгованого вивільнення, що містить теобромін UA103558C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020090105137A KR101137467B1 (ko) 2009-11-02 2009-11-02 테오브로민 함유 서방성 정제
PCT/KR2010/005911 WO2011052884A2 (ko) 2009-11-02 2010-09-01 테오브로민 함유 서방성 정제

Publications (1)

Publication Number Publication Date
UA103558C2 true UA103558C2 (uk) 2013-10-25

Family

ID=43922740

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201206606A UA103558C2 (uk) 2009-11-02 2010-09-01 Таблетка пролонгованого вивільнення, що містить теобромін

Country Status (7)

Country Link
KR (1) KR101137467B1 (uk)
CN (1) CN102711740B (uk)
BR (1) BR112012010325B8 (uk)
RU (1) RU2506947C2 (uk)
TR (1) TR201205029T1 (uk)
UA (1) UA103558C2 (uk)
WO (1) WO2011052884A2 (uk)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101220830B1 (ko) * 2010-08-18 2013-01-10 안국약품 주식회사 테오브로민의 서방성 과립제 및 그 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196481A1 (en) * 2002-07-25 2007-08-23 Amidon Gregory E Sustained-release tablet composition
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
KR20070017335A (ko) * 2004-03-22 2007-02-09 노파르티스 아게 리카르바제핀을 포함하는 경구투여용 매트릭스 제제
CN101111231A (zh) * 2005-03-29 2008-01-23 罗姆有限公司 包含具有影响调节物质递送的基质的小丸的多颗粒药用形式
KR100762847B1 (ko) * 2006-01-27 2007-10-04 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법

Also Published As

Publication number Publication date
KR20110048367A (ko) 2011-05-11
WO2011052884A2 (ko) 2011-05-05
CN102711740B (zh) 2014-02-12
BR112012010325A2 (pt) 2016-03-29
WO2011052884A3 (ko) 2011-07-14
KR101137467B1 (ko) 2012-04-20
BR112012010325B8 (pt) 2021-05-25
CN102711740A (zh) 2012-10-03
RU2506947C2 (ru) 2014-02-20
TR201205029T1 (tr) 2012-09-21
RU2012119070A (ru) 2013-12-10
BR112012010325B1 (pt) 2021-01-26

Similar Documents

Publication Publication Date Title
EA017091B9 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
IN2012DN01378A (uk)
PT2043600T (pt) Formulações farmacêuticas para a libertação prolongada de princípio(s) ativo(s), assim como suas aplicações, nomeadamente terapêuticas
MX2009004746A (es) Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
TNSN08191A1 (en) Kinase inhibitors
UA89394C2 (uk) Композиція оланзапіну або донепезилу, що розпадається при пероральному прийомі
EA201201263A1 (ru) Фармацевтическая композиция, содержащая этексилат дабигатрана
PL1842534T3 (pl) Tabletki bursztynianu metoprololu o przedłużonym uwalnianiu oraz sposoby ich wytwarzania
MX2009006567A (es) Pirimidinilpirazoles como principios activos insecticidas y parasiticidas.
MY151005A (en) Amide compounds as boosters of antivirals
TW200738627A (en) Trialkylsilyl-indoles
RU2008135718A (ru) Композиции клопидогреля бисульфата
MX2011010359A (es) Composición de 2,4,6-trifluoro-n-[6-(1-metilo-piperidina-4-carboni lo)-piridina-2-ilo]-benzamida.
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
CY1109865T1 (el) Συνθεσεις βαλσαρτανης
MX2010007892A (es) Imidazopiridazinas como inhibidores de par1, su produccion y uso como medicamentos.
UA103558C2 (uk) Таблетка пролонгованого вивільнення, що містить теобромін
WO2011064797A3 (en) Controlled release pharmaceutical compositions of galantamine
MY152040A (en) Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
ATE438381T1 (de) Zolpidemtabletten
MX2012007393A (es) Composicion farmaceutica de disolucion rapida comprendiendo lornoxicam.
WO2012153347A3 (en) Oral pharmaceutical composition of olanzapine form 1 and sodium starch glycolate
WO2007093168A3 (de) Schnell freisetzende irbesartan-haltige pharmazeutische zusammensetzung
WO2011132008A3 (en) Controlled release pharmaceutical composition